Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michal Mandelboim and Limor Kliker.
Michal Mandelboim
Connection Strength
0.654
Limor Kliker
  1. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro Surveill. 2021 07; 26(26).
    View in: PubMed
    Score: 0.238
  2. Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2. N Engl J Med. 2021 06 24; 384(25):2453-2454.
    View in: PubMed
    Score: 0.235
  3. The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R. Vaccines (Basel). 2021 Aug 23; 9(8).
    View in: PubMed
    Score: 0.060
  4. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
    View in: PubMed
    Score: 0.060
  5. Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1. J Infect Dis. 2021 08 16; 224(4):616-619.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.